# Preoperative Radiotherapy and E7046 in Rectum Cancer

> **NCT03152370** · PHASE1 · COMPLETED · sponsor: **Adlai Nortye Biopharma Co., Ltd.** · enrollment: 29 (actual)

## Conditions studied

- Neoadjuvant Therapy in Rectal Cancer

## Interventions

- **DRUG:** E7046
- **RADIATION:** Long Course Chemoradiotherapy (LCRT)
- **RADIATION:** Short Course Radiotherapy (SCRT)
- **DRUG:** capecitabine
- **DRUG:** folinic acid/5-FU/oxaliplatin (mFOLFOX-6)

## Key facts

- **NCT ID:** NCT03152370
- **Lead sponsor:** Adlai Nortye Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152370, "Preoperative Radiotherapy and E7046 in Rectum Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03152370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*